Erythromycin: Uses, Dosage & Side Effects

What Is Erythromycin and What Is It Used For?

Erythromycin is a naturally occurring macrolide antibiotic that was first isolated in 1952 from a soil sample in the Philippines, produced by the actinomycete bacterium Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus). It was one of the first macrolide antibiotics introduced into clinical practice and quickly became an essential tool in the treatment of bacterial infections, particularly for patients who could not tolerate penicillin. More than seven decades after its discovery, erythromycin remains a clinically relevant antibiotic listed on the World Health Organization (WHO) Model List of Essential Medicines.

Chemically, erythromycin features a 14-membered macrolactone ring with two sugar moieties (desosamine and cladinose) attached. The stearate salt form used in oral tablets provides improved acid stability compared to the erythromycin base, allowing better absorption from the gastrointestinal tract. After oral administration of erythromycin stearate tablets, the drug dissociates in the duodenum, and free erythromycin base is absorbed from the small intestine. Peak serum concentrations are typically achieved within 2 to 4 hours after dosing, though absorption is reduced when the drug is taken with food, which is why erythromycin stearate should be taken on an empty stomach.

Erythromycin works by reversibly binding to the 50S ribosomal subunit of susceptible bacteria, specifically at the 23S ribosomal RNA component. This binding blocks the translocation of aminoacyl transfer-RNA during protein synthesis, effectively preventing the bacterium from producing essential proteins needed for growth and reproduction. At standard therapeutic concentrations, erythromycin is primarily bacteriostatic (inhibiting bacterial growth), but it can be bactericidal (directly killing bacteria) at higher concentrations against particularly susceptible organisms such as Streptococcus pyogenes (group A streptococci) and Streptococcus pneumoniae.

The antibiotic distributes widely throughout body tissues and fluids, achieving concentrations in tissues that often exceed those found in blood plasma. It crosses the placental barrier and is excreted in breast milk. Erythromycin is primarily metabolized in the liver by the cytochrome P450 enzyme CYP3A4 and is excreted predominantly in bile, with only a small fraction eliminated through the kidneys. This hepatic metabolism is clinically significant because erythromycin is also a potent inhibitor of CYP3A4, which gives it a substantial drug interaction profile.

Erythromycin has a broad spectrum of activity and is approved for the treatment of the following infections caused by susceptible organisms:

• Lower respiratory tract infections: Acute bronchitis, exacerbation of chronic bronchitis, and other lower airway infections caused by susceptible organisms including Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae.
• Sinusitis: Acute and chronic bacterial sinusitis, particularly when caused by gram-positive organisms susceptible to erythromycin.
• Community-acquired pneumonia: Mild to moderate pneumonia, including atypical pneumonia caused by Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila. Erythromycin was historically the drug of choice for Legionnaires' disease.
• Skin and soft tissue infections: Cellulitis, erysipelas (a superficial skin infection with characteristic raised, well-defined borders), boils (furuncles and carbuncles), and other superficial skin infections caused by susceptible streptococci and staphylococci.
• Prevention of rheumatic fever: Long-term prophylaxis to prevent recurrent episodes of rheumatic fever in patients allergic to penicillin, the standard first-line prophylactic agent.
• Non-gonococcal urethritis: Urethritis not caused by Neisseria gonorrhoeae, typically caused by Chlamydia trachomatis or Ureaplasma urealyticum.

Beyond its approved indications, erythromycin has several noteworthy off-label uses. It is used as a prokinetic agent in low doses to stimulate gastric motility by acting as a motilin receptor agonist, which can be helpful in conditions such as gastroparesis and post-operative ileus. Topical erythromycin formulations are widely used in dermatology for the treatment of acne vulgaris. Additionally, erythromycin ophthalmic ointment is routinely used in newborns for the prevention of ophthalmia neonatorum (neonatal conjunctivitis caused by Neisseria gonorrhoeae and Chlamydia trachomatis).

Erythromycin is classified as an Access antibiotic under the WHO AWaRe (Access, Watch, Reserve) classification system. This means it is a first- or second-choice antibiotic for many common infections and should be widely available, affordable, and quality-assured. Appropriate use of Access antibiotics is a key component of global antimicrobial stewardship strategies aimed at combating antibiotic resistance.

What Should You Know Before Taking Erythromycin?

Erythromycin is generally a safe and well-established antibiotic when used appropriately, but there are important considerations and contraindications that must be evaluated before starting treatment. Because erythromycin is a potent inhibitor of the hepatic CYP3A4 enzyme system and can affect cardiac electrical conduction, it has more contraindications and precautions than many other commonly used antibiotics. Your prescribing physician will assess your individual risk factors, medical history, and current medications to determine whether erythromycin is the right choice for you.

Contraindications

You must not take erythromycin in the following situations:

• Allergy to erythromycin or any macrolide antibiotic: If you have ever had an allergic reaction to erythromycin, clarithromycin, azithromycin, or any other macrolide antibiotic, you should not take erythromycin. Cross-sensitivity between macrolides is common.
• Concurrent use with vasoconstrictors: Erythromycin must not be taken together with ergotamine or dihydroergotamine. This combination can lead to dangerously constricted blood vessels (ergotism), potentially causing tissue damage or even gangrene in the extremities.
• Concurrent use with certain antihistamines: The combination of erythromycin with astemizole or terfenadine is contraindicated because erythromycin significantly raises blood levels of these drugs, increasing the risk of fatal cardiac arrhythmias (torsades de pointes).
• Concurrent use with cisapride, pimozide, or domperidone: Each of these drugs carries an independent risk of QT prolongation, and combining them with erythromycin (which also prolongs the QT interval) creates an unacceptably high risk of serious cardiac arrhythmias.
• Concurrent use with lomitapide: Taking erythromycin together with lomitapide (a cholesterol-lowering medication) can cause a dramatic increase in lomitapide levels, leading to liver toxicity with elevated liver enzymes (transaminases).
• Severe liver impairment: Erythromycin is extensively metabolized by the liver, and its use in patients with severely impaired hepatic function can lead to drug accumulation and increased toxicity.
• Known QT prolongation or electrolyte imbalances: If you or a family member have a history of QT prolongation, torsades de pointes, or other ventricular arrhythmias, or if you have low potassium (hypokalemia) or low magnesium (hypomagnesemia), erythromycin should not be used due to its potential to further prolong the QT interval.

Warnings and Precautions

Talk to your doctor before taking erythromycin if any of the following apply to you:

• Impaired liver function: Even with mildly to moderately reduced liver function, your doctor may need to adjust the dose or monitor you more closely. Cases of hepatitis (liver inflammation) with or without jaundice have been reported with erythromycin use. Symptoms of liver problems include yellowing of the skin or eyes, dark urine, pale stools, persistent nausea, or upper abdominal pain. Stop erythromycin and seek medical attention immediately if these symptoms develop.
• Myasthenia gravis: Erythromycin may worsen symptoms of muscle weakness in patients with this condition. If you have myasthenia gravis, your doctor should carefully weigh the benefits against the risks before prescribing erythromycin.
• Heart conditions: If you have any heart problems, including coronary artery disease, heart failure, conduction abnormalities, or bradycardia (slow heart rate), inform your doctor. Erythromycin has been associated with QT interval prolongation, which can predispose to serious cardiac arrhythmias.
• Concurrent use with statins: Combining erythromycin with HMG-CoA reductase inhibitors (statins) such as simvastatin or lovastatin can significantly increase statin blood levels, raising the risk of rhabdomyolysis (a serious condition involving the breakdown of skeletal muscle tissue that can lead to kidney failure). If you take a statin, your doctor may temporarily discontinue it or switch to a statin with lower interaction potential during erythromycin therapy.
• Diarrhea during or after treatment: If you develop diarrhea or abdominal pain during or after erythromycin treatment, contact your doctor. These could be symptoms of Clostridioides difficile colitis (pseudomembranous colitis), a potentially serious bowel infection that can occur with nearly any antibiotic. This condition can develop even more than 2 months after completing treatment.
• Mitochondrial disorders: There is a risk of vision impairment in patients with underlying mitochondrial metabolic disorders. Inform your doctor if you have a known or suspected mitochondrial condition.

Pregnancy and Breastfeeding

If you are pregnant, think you may be pregnant, or are planning to have a baby, consult your doctor before taking erythromycin. The active substance in erythromycin crosses the placenta and reaches the developing fetus, and it is also excreted in breast milk. Data from studies evaluating the risk of birth defects are inconsistent, but some studies have reported a possible association with congenital heart defects when erythromycin is used during early pregnancy (particularly the first trimester).

The European Medicines Agency (EMA) and the British National Formulary (BNF) advise that erythromycin should only be used during pregnancy when the expected benefit to the mother clearly outweighs the potential risk to the fetus. In practice, erythromycin has been used for decades in pregnant women and is sometimes considered when other antibiotics are not suitable, but newer macrolides or alternative antibiotic classes may be preferred depending on the clinical situation. Mothers who are pregnant and treated with erythromycin for early syphilis should be aware that erythromycin may not reach the fetus in adequate concentrations, and the newborn may need additional treatment with an appropriate penicillin.

Regarding breastfeeding, erythromycin is excreted into human breast milk in small quantities. The BNF notes that erythromycin is generally considered compatible with breastfeeding in short courses, but the potential for effects on the infant, including diarrhea or thrush, should be discussed with your healthcare provider.

Driving and Operating Machinery

Erythromycin can occasionally cause dizziness, confusion, hallucinations, or seizures, all of which can impair your ability to drive or operate heavy machinery. If you experience any of these side effects, do not drive or use machines until the symptoms have completely resolved. Most patients taking erythromycin do not experience these neurological effects, but it is important to be aware of the possibility, particularly when beginning treatment.

How Does Erythromycin Interact with Other Drugs?

Erythromycin is one of the most potent clinically relevant inhibitors of the cytochrome P450 3A4 (CYP3A4) enzyme in the liver, which is responsible for the metabolism of a large proportion of all medications. By inhibiting this enzyme, erythromycin can significantly increase the blood concentration of drugs that are metabolized by CYP3A4, potentially leading to enhanced therapeutic effects or, more concerningly, increased toxicity. This mechanism underlies the majority of erythromycin's drug interactions and is the reason why a thorough medication review is essential before starting erythromycin therapy.

In addition to CYP3A4 inhibition, erythromycin can independently prolong the QT interval on an electrocardiogram (ECG), which can predispose to potentially fatal ventricular arrhythmias, particularly torsades de pointes. Combining erythromycin with other QT-prolonging drugs amplifies this risk substantially and is generally to be avoided.

Major Interactions (Contraindicated or Clinically Significant)

Moderate Interactions (May Require Dose Adjustment or Monitoring)

Drugs That May Reduce Erythromycin's Effectiveness

Certain medications can reduce the blood levels of erythromycin by inducing its metabolism (increasing the rate at which it is broken down in the liver). If you are taking any of the following drugs, your doctor may need to consider an alternative antibiotic or adjust the erythromycin dose:

• Rifampicin – a powerful CYP3A4 inducer that can substantially reduce erythromycin levels
• Phenytoin – can reduce erythromycin levels while simultaneously having its own levels increased by erythromycin (bidirectional interaction)
• Carbamazepine – similar bidirectional interaction as with phenytoin
• Phenobarbital – enzyme inducer that can lower erythromycin efficacy
• St. John's Wort (Hypericum perforatum) – a herbal supplement that is a potent CYP3A4 inducer and should be avoided during erythromycin treatment

Interactions with Other Antibiotics

Erythromycin may reduce the effectiveness of certain other antibiotics when used concurrently. This is because macrolides like erythromycin and certain other antibiotic classes (such as penicillins and cephalosporins) may have antagonistic mechanisms of action. Specifically, erythromycin can potentially diminish the bactericidal effect of the following drugs:

• Penicillins (e.g., amoxicillin, penicillin V)
• Cephalosporins
• Clindamycin and lincomycin (may also compete for the same ribosomal binding site)
• Chloramphenicol
• Streptomycin
• Tetracyclines
• Colistin

What Is the Correct Dosage of Erythromycin?

Always take erythromycin exactly as prescribed by your doctor or pharmacist. The dose, frequency, and duration of treatment will depend on the type and severity of your infection, your age, body weight, and kidney and liver function. Do not change the dose or stop treatment early without consulting your healthcare provider, even if you start to feel better, as stopping antibiotics prematurely can lead to treatment failure and contribute to antibiotic resistance.

Adults

Children

Children's doses are calculated based on body weight. The standard dose is 30–50 mg/kg per day divided into several doses. For severe infections, the doctor may double the dose. The following table provides age-based dosing guidance:

For children under 8 years, infants, and newborns, an oral suspension (liquid formulation) of erythromycin is generally recommended rather than tablets, as it allows more accurate dosing and is easier to swallow. Tablets are typically reserved for older children who can swallow them whole.

Elderly Patients

There is no specific dose adjustment recommended solely based on age. However, elderly patients are more likely to have reduced liver and kidney function, as well as other comorbidities and polypharmacy (use of multiple medications), which may necessitate dose adjustments or more frequent monitoring. Your doctor will take your overall health status into account when prescribing erythromycin.

Patients with Impaired Liver or Kidney Function

If you have impaired liver function, your doctor may need to reduce the dose or monitor liver enzymes more frequently during treatment, as erythromycin is primarily metabolized by the liver and can cause hepatotoxicity. If you have significant kidney impairment, dose adjustments may also be considered, although erythromycin is primarily eliminated through the bile rather than the kidneys.

How to Take Erythromycin

• Take the tablets 1 hour before a meal on an empty stomach for optimal absorption.
• Swallow the tablets whole with a full glass of water. Do not crush, chew, or break the film-coated tablets.
• Try to take your doses at evenly spaced intervals throughout the day to maintain consistent drug levels in your body.
• Complete the entire prescribed course of treatment, even if your symptoms improve before the course is finished.

Missed Dose

If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one.

Overdose

If you have taken more erythromycin than prescribed, or if a child has accidentally ingested the medication, contact a poison control center or emergency medical services immediately. Symptoms of overdose may include severe nausea, vomiting, abdominal cramps, and diarrhea. There is no specific antidote for erythromycin overdose; treatment is supportive and may include gastric lavage (stomach pumping) and administration of activated charcoal if the ingestion was recent. Ensure that you drink plenty of fluids to stay hydrated.

Stopping Treatment

Always complete the full course of antibiotics as prescribed by your doctor. If you stop treatment early, not all the bacteria causing your infection may be killed, which can lead to a recurrence of the infection or the development of antibiotic-resistant bacteria. If you experience side effects that make it difficult to continue treatment, contact your doctor rather than stopping on your own, as they may be able to adjust the dose, switch to a different formulation, or recommend an alternative antibiotic.

What Are the Side Effects of Erythromycin?

Like all medicines, erythromycin can cause side effects, although not everyone experiences them. The majority of erythromycin side effects are gastrointestinal and are generally mild and self-limiting. However, some serious side effects can occur and require prompt medical attention. Erythromycin stimulates motilin receptors in the gastrointestinal tract, which is why stomach-related side effects are more common with this antibiotic compared to newer macrolides like azithromycin or clarithromycin.

The following frequency grid categorizes known side effects by how commonly they occur:

If you notice any side effects not listed here, or if any of the listed side effects become severe or persistent, contact your doctor or pharmacist. Reporting side effects to your national medicine regulatory authority helps to continuously monitor the benefit-risk balance of erythromycin and contributes to ongoing drug safety surveillance.

How Should You Store Erythromycin?

Proper storage of erythromycin is essential to ensure that the medication remains effective and safe throughout its shelf life. Erythromycin stearate film-coated tablets should be stored according to the following guidelines:

• Temperature: Store at a temperature not exceeding 25°C (77°F). Do not freeze the tablets. Avoid storing in locations that may experience extreme temperatures, such as near radiators, on sunny windowsills, or in vehicles during hot weather.
• Light protection: Erythromycin is light-sensitive. Keep the tablets in their original packaging to protect them from light. Do not transfer the tablets to transparent or translucent containers.
• Moisture protection: Erythromycin is moisture-sensitive. Keep the container tightly closed and avoid storing the medication in humid environments such as bathrooms.
• Child safety: Keep this medication out of the sight and reach of children. Use child-resistant packaging where available and store medications in a locked cabinet if possible.
• Expiration date: Do not use erythromycin after the expiration date printed on the packaging (abbreviated EXP). The expiration date refers to the last day of the month indicated.
• Disposal: Do not dispose of unused or expired medications in household waste or by flushing them down the drain. Return unused medications to your pharmacy for safe and environmentally responsible disposal.

What Does Erythromycin Contain?

Understanding the composition of your medication can be important, particularly if you have known allergies or sensitivities to specific pharmaceutical excipients (inactive ingredients). The full composition of erythromycin stearate film-coated tablets is as follows:

Active Ingredient

The active substance is erythromycin stearate. Each film-coated tablet contains erythromycin stearate equivalent to 250 mg of erythromycin. The stearate salt form improves the stability of erythromycin in the acidic environment of the stomach, ensuring that more of the drug reaches the small intestine where it can be absorbed effectively.

Inactive Ingredients (Excipients)

The tablets also contain the following inactive ingredients, which serve various pharmaceutical functions such as binding, coating, and stabilizing the tablet:

• Povidone K30 (E1201) – A binding agent that helps hold the tablet together
• Maize starch – Used as a filler and disintegrant to help the tablet break apart after swallowing
• Magnesium hydroxide (E528) – An antacid component that helps buffer the tablet; note that in young children, this ingredient can potentially lead to elevated magnesium levels (hypermagnesemia), particularly in those with impaired kidney function or dehydration
• Polacrilin potassium – A disintegrant that promotes rapid tablet disintegration
• Macrogol 8000 and Macrogol 400 – Used in the film coating to improve tablet smoothness and swallowability
• Hypromellose 2910 (E464) – A film-forming polymer used in the tablet coating
• Sorbic acid – A preservative that helps maintain the stability and shelf life of the tablet

Tablet Appearance

Erythromycin stearate tablets (as marketed under the Abboticin brand) are film-coated tablets with a manufacturer's monogram on one side. The tablets are available in packs of 30, 40, or 100 tablets. The film coating protects the active ingredient from degradation by stomach acid and helps mask the characteristically bitter taste of erythromycin.